Gain Therapeutics, Inc. - Common Stock — Quarterly Financial Statistics (NASDAQ:GANX) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities -3.82 M-5.1 M-4.93 M-4.62 M-4.73 M -19.37 M Cash from investing activities 3.02 M2 M-1-43.45 K— — Cash from financing activities 2.4 M2.47 M7.03 M16.55 M404.32 K 26.46 M Free cash flow -3.82 M-5.1 M-4.93 M-4.62 M-4.73 M -19.37 M

News

Gain Therapeutics reports 81% reduction in Parkinson’s biomarker

Why GH Research Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket - BioAtla (NASDAQ:BCAB), ChowChow Cloud Internatio (AMEX:CHOW)

Gain Therapeutics (GANX) Upgraded to Buy: Here's Why

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.14%

Is Enhabit, Inc. (EHAB) Stock Outpacing Its Medical Peers This Year?

Here's Why Gain Therapeutics, Inc. (GANX) is a Great Momentum Stock to Buy

H.C. Wainwright reiterates Buy rating on Gain Therapeutics stock ahead of trial data

Gain Therapeutics files prospectus supplement for $35.5 million stock offering

Gain Therapeutics (GANX) Upgraded to Buy: Here's What You Should Know

Gain Therapeutics stock rating reiterated at Buy by H.C. Wainwright

Gain Therapeutics reports preliminary Phase 1b data for Parkinson’s drug GT-02287

Gain Therapeutics reports positive early data from Parkinson’s trial